Ypsomed Holding AG
YPSN
Peringkat dalam Saham
#2943
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Harga Saham
$468.18
Kapitalisasi Pasar
$6.16B
Perubahan (1 hari)
1.37%
Perubahan (1 tahun)
18.68%
Negara
CH
Perdagangan Ypsomed Holding AG (YPSN)
Kategori
Healthcare
Laba untuk Ypsomed Holding AG (YPSN)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Ypsomed Holding AG, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Ypsomed Holding AG dari 2002 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2025 | $117.99M | 30.03% |
| 2024 | $90.74M | 46.62% |
| 2023 | $61.89M | 123.73% |
| 2022 | $27.66M | 327.21% |
| 2021 | $6.48M | -20.72% |
| 2020 | $8.17M | -88.37% |
| 2019 | $70.22M | 8.04% |
| 2018 | $64.99M | 17.69% |
| 2017 | $55.22M | 23.00% |
| 2016 | $44.90M | 83.56% |
| 2015 | $24.46M | 41.99% |
| 2014 | $17.23M | 430.74% |
| 2013 | $3.25M | -69.86% |
| 2012 | $10.77M | 28.52% |
| 2011 | $8.38M | -25.03% |
| 2010 | $11.18M | -51.37% |
| 2009 | $22.98M | -23.06% |
| 2008 | $29.87M | 1,042.95% |
| 2007 | $2.61M | -94.71% |
| 2006 | $49.41M | 29.32% |
| 2005 | $38.20M | 235.81% |
| 2004 | $11.38M | 8.53% |
| 2003 | $10.48M | 159.63% |
| 2002 | $4.04M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $1.09B | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $74.36M | - |
KR
|
